Clinical trials
Completed Substance-Related Disorders trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| Central Institute of Mental Health, Mannheim | 1 |
| Charite University, Berlin, Germany | 1 |
| Silke Wiegand-Grefe, Prof. Dr. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Substance-Related Disorders | 5 |
| Alcoholism | 1 |
| Hepatitis C | 1 |
| Mental Disorders | 1 |
| Mood Disorders | 1 |
| Neurotic Disorders | 1 |
| Personality Disorders | 1 |
| Schizophrenia Spectrum and Other Psychotic Disorders | 1 |
| Tobacco Use Disorder | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.